Shusen Zheng

Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis

Kangjie Chen, Shengzhang Lin, Lin Zhou et al. · PLoS ONE · 2011 · 240 citations · Full text

Medicine, Immunology, Oncology +16

Increased circulating <scp>L</scp>in^−/low<scp>CD</scp>33⁺<scp>HLA‐DR</scp>⁻ myeloid‐derived suppressor cells in hepatocellular carcinoma patients

Peng Shen, Aijuan Wang, Mengye He et al. · Hepatology Research · 2013 · 71 citations · Full text

Medicine, Immunology, Oncology +14

APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024

George Lau, Shuntaro Obi, Jian Zhou et al. · Hepatology International · 2024 · 51 citations · Full text

Medicine, Immunology, Oncology +17

Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway

Limin Ding, Junjie Qian, Xizhi Yu et al. · Cancer Letters · 2023 · 45 citations

Medicine, Immunology, Oncology +17

B7‐H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL‐10 levels

Lei Geng, Guo‐Ping Jiang, Yun Fang et al. · Journal of Viral Hepatitis · 2006 · 39 citations

Life Sciences, Immunology, Infectious Diseases +11